Freeline Therapeutics Company
AAV based gene therapy, liver, chronic inflammatory diseases.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2015
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
9
Total Funding:
$276M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Register and Claim Ownership